BioCentury
ARTICLE | Company News

Phylogica, PhoreMost deal

May 4, 2015 7:00 AM UTC

Phylogica granted PhoreMost non-exclusive, worldwide rights to use undisclosed Phylomer libraries to screen cancer targets and to identify and develop small molecule drug candidates against those targ...